Lower ‘white coat effect’ boosts COVAX
COMMUNITY pharmacies are playing a key role in the rollout of COVID-19 vaccines (COVAX), with the approachability of pharmacists heralded as a possible factor in geng hesitant pa ents immunised.
Pharmacy Plaorm’s Programs and Services Manager, Krys ‐Lee Rigby, noted that the reduced ‘white coat effect’ experienced by pa ents in pharmacy sengs could be a factor in boos ng the uptake of vaccines through the community pharmacy network.
“The ‘white coat effect’ gets its name from doctors and medical staff who wear white coats in clinical sengs that can trigger anxiety levels that clinically raise blood pressure,” she said.
“While we know that higher levels of COVID‐19 circula ng in the community, par cularly in NSW, has contributed to accelerated vaccine uptake, we also think access to approachable pharmacists has played a role.
“You don’t need to make an appointment to chat with your pharmacist, so it can feel less daun ng approaching your local pharmacist for a chat if you have ques ons or concerns about available vaccines.
“Customers can start with a chat and then go away and think about their op ons without feeling pressured.”
Rigby added that the convenience of the pharmacy network was another factor behind the success of the vaccina on campaign.
“Pharmacists are capable of doing so much more than filling scripts and advising on the best shampoo to treat hair lice,” she said.
“They’re highly skilled health providers with deep knowledge and exper se – the pandemic is illumina ng that.
“Pharmacies also allow walk-ins, which works well for spontaneous millennials or those who’ve experienced difficulty trying to book online or call a hotline.
“There’s a huge convenience factor for shi workers as most pharmacies are open for late trade seven days per week.”